Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients
The clinical course of unselected patients with PPGL is rather benign. Survival rates remain high for decades, unless there are MACE before diagnosis or metastatic disease.
Authors
- Reinhard Lehner (ORCID: https://orcid.org/0000-0001-7690-475X)
- Cornelia Gabler (ORCID: https://orcid.org/0000-0002-7336-6260)
- Petra Zeitlhofer
- Harald Esterbauer (ORCID: https://orcid.org/0000-0001-7343-7455)
- Sabina M. Baumgartner-Parzer (ORCID: https://orcid.org/0000-0002-0928-6119)
- Raphael Schendl
- Andreas Scheuba (ORCID: https://orcid.org/0009-0007-2536-1573)
- Wolfgang Raber (ORCID: https://orcid.org/0000-0003-2289-5696)
- Melisa Arikan
- Peter Mazal (ORCID: https://orcid.org/0000-0002-9586-6231)
- Valerie Stadlmann
Institutions
- St Anna Children's Hospital (AT)
- St. Anna Children's Cancer Research Institute
- Medical University of Vienna (AT)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.3389/fendo.2024.1419028
- Citations
- 8
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 4.58